Undesirable Side-effects from Decamethonium Iodide
نویسندگان
چکیده
منابع مشابه
Decamethonium iodide: a reappraisal.
DECAMETHONIUM iodide (CIO) was first described by Barlow and Ing, and by Paton and Zaimis, in 1948. The following year it was introduced into anaesthesia as a result of the work of Organe, and of Hewer, Lucas, Prescott and Rowbotham. Apart from the initial enthusiasm decamethonium has never found much favour with anaesthetists. In 1950 an editorial in the Lancet, comparing it with Gallamine, st...
متن کاملThe action of decamethonium iodide (C.10) in myasthenia gravis.
Myasthenia gravis is a chronic disease characterized by abnormal fatigue of the voluntary muscles. This fatigue is due to a progressive failure of conduction at the myoneural junction after muscle contraction, and can be temporarily relieved by prostigmine sulphate (Walker, 1934). The exact nature of the neuromuscular block remains obscure, and an analysis of neuromuscular transmission in myast...
متن کاملHow to overcome undesirable effects
Power transformers are still among the most costly and critical components in an electrical power network. Thus, the importance of a reliable condition assessment of these assets increases due to the aging of transformer fleets. The Sweep Frequency Response Analysis (SFRA) has become an important standard test and provides comprehensive information about the mechanical and electrical integrity ...
متن کاملPolycation-mediated transfection: how to overcome undesirable side effects of sticky DNA complexes.
Using polycationic transfection one encounters undesired persistent binding to cells of sticky polycation/DNA complexes. These complexes simulate transfection under conditions where no uptake is expected e.g. at 4 degrees C if the uptake is by endocytosis. To overcome this problem, using H1/DNA complexes, we developed an easy and nontoxic method for removing the sticky complexes not taken up du...
متن کاملLevetiracetam-Induced Skin Hyperpigmentation: An Extremely Rare Undesirable Side Effect
Levetiracetam is one of the newer second-generation antiepileptic drugs with multiple mechanisms of action. Cutaneous side effects due to levetiracetam are rarely reported in the literature. In this article, we describe a patient with skin hyperpigmentation due to the treatment with levetiracetam with complete resolution after discontinuation of the medication. In addition, we review the topic ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1952
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.1.4772.1329